{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:29:05Z","timestamp":1780572545712,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["RFMEFI61614\u00d70010"],"award-info":[{"award-number":["RFMEFI61614\u00d70010"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.phymed.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T18:15:14Z","timestamp":1453745714000},"page":"1190-1197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cellular models of atherosclerosis and their implication for testing natural substances with anti-atherosclerotic potential"],"prefix":"10.1016","volume":"23","author":[{"given":"Alexander N.","family":"Orekhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3159-2881","authenticated-orcid":false,"given":"Ekaterina A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2016.01.003_bib0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9150(88)90087-1","article-title":"Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists","volume":"72","author":"Akopov","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0003","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/jmf.2012.0285","article-title":"Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia","volume":"16","author":"Al-Waili","year":"2013","journal-title":"J Med Food"},{"key":"10.1016\/j.phymed.2016.01.003_bib0004","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2016.01.003_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(96)06056-X","article-title":"Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta","volume":"130","author":"Andreeva","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0040-8166(05)80069-2","article-title":"Gap junctional communication in primary culture of cells derived from human aortic intima","volume":"27","author":"Andreeva","year":"1995","journal-title":"Tissue Cell"},{"key":"10.1016\/j.phymed.2016.01.003_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(86)90027-4","article-title":"Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations","volume":"59","author":"Antonov","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0008","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1755-5922.2010.00189.x","article-title":"Nutraceuticals and atheroslcerosis: human trials","volume":"28","author":"Badimon","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phymed.2016.01.003_bib0009","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phymed.2016.01.003_bib0011","first-page":"S324","article-title":"Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells","volume":"47","author":"Baldenkov","year":"1988","journal-title":"Biomed. Biochim. Acta."},{"key":"10.1016\/j.phymed.2016.01.003_bib0012","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","article-title":"Statin intolerance \u2013 an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"14","author":"Banach","year":"2015","journal-title":"Expert Opin. Drug Safety"},{"key":"10.1016\/j.phymed.2016.01.003_bib0013","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2016.01.003_bib0017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(86)92426-8","article-title":"Atherogenicity of blood serum from patients with coronary heart disease","volume":"2","author":"Chazov","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2016.01.003_bib0018","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/17512433.2015.1012494","article-title":"How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease","volume":"8","author":"Diamond","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0019","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2016.01.003_bib0021","first-page":"538","article-title":"Trapidil derivatives as potential anti-atherosclerotic drugs","volume":"37-I","author":"Giessler","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.phymed.2016.01.003_bib0022","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.76.3.504","article-title":"Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis","volume":"76","author":"Goldstein","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2016.01.003_bib0023","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1567-5688(05)80267-3","article-title":"The suppression of the inflammatory cytokines expression by natural substances","volume":"6","author":"Gorchakova","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0024","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10517-007-0099-6","article-title":"Use of natural products in anticytokine therapy","volume":"143","author":"Gorchakova","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phymed.2016.01.003_bib0025","first-page":"492","article-title":"The reduction of proinflammatory cytokine expression by natural components: a new approach to the prevention and treatment of atherosclerosis at the cellular level","volume":"1","author":"Gorchakova","year":"2007","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0026","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1567-5688(07)71854-8","article-title":"Combined anti-inflammatory and anti-atherogenic activity of natural drug Inflaminat \u2013 a perspective for long-term atherosclerosis prevention and treatment","volume":"8","author":"Gorchakova","year":"2007","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phymed.2016.01.003_bib0027","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1567-5688(09)70682-8","article-title":"Atherosclerosis prevention with the anti-inflammatory dietary supplement Inflaminat","volume":"10","author":"Gorchakova","year":"2009","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phymed.2016.01.003_bib0028","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.imbio.2012.01.008","article-title":"Monocytes as a diagnostic marker of cardiovascular diseases","volume":"217","author":"Gratchev","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.phymed.2016.01.003_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ddr.430190310","article-title":"Influence of trapidil and trapidil derivatives on the content of cyclic nucleotides in human intima cells cultured from atherosclerotic plaques","volume":"19","author":"Heinroth-Hoffmann","year":"1990","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fitote.2013.01.003","article-title":"Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies","volume":"85","author":"Hopkins","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phymed.2016.01.003_bib0033","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00019501-199304000-00010","article-title":"Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease","volume":"4","author":"Jaakkola","year":"1993","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.phymed.2016.01.003_bib0036","first-page":"417","article-title":"Nikolai N. Anichkov and his theory of atherosclerosis","volume":"33","author":"Konstantinov","year":"2006","journal-title":"Tex Heart Inst. J."},{"key":"10.1016\/j.phymed.2016.01.003_bib0037","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1567-5688(06)81795-2","article-title":"Bioflavonoid-rich botanicals reduce blood serum atherogenicity in perimenopausal women","volume":"7","author":"Korennaya","year":"2006","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phymed.2016.01.003_bib0038","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(99)00060-X","article-title":"The antiatherosclerotic effect of Allium sativum","volume":"144","author":"Koscielny","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0039","first-page":"S284","article-title":"Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins","volume":"43","author":"Kudryashov","year":"1984","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.phymed.2016.01.003_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ddr.430170203","article-title":"Anti-atherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture","volume":"17","author":"Li","year":"1989","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0041","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0042","first-page":"437","article-title":"Atherosclerosis in youth","volume":"54","author":"McGill","year":"2002","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.phymed.2016.01.003_bib0043","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.phymed.2016.01.003_bib0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1567-5688(08)70689-5","article-title":"Background, rationale and design of clinical study of the effect of isoflavonoid-rich botanicals on natural history of atherosclerosis in women","volume":"9","author":"Myasoedova","year":"2008","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phymed.2016.01.003_bib0046","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s10517-006-0260-7","article-title":"Antiatherogenic effect of grape flavonoids in an ex vivo model","volume":"141","author":"Nikitina","year":"2006","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phymed.2016.01.003_bib0047","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(83)90555-X","article-title":"Prostacyclin analogues as anti-atherosclerotic drugs","volume":"2","author":"Orekhov","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2016.01.003_bib0048","first-page":"255","article-title":"Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta","volume":"62","author":"Orekhov","year":"1984","journal-title":"Med. Biol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0049","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(84)91574-5","article-title":"Artificial HDL as an anti-atherosclerotic drug","volume":"2","author":"Orekhov","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2016.01.003_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-4800(85)90022-X","article-title":"Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells","volume":"42","author":"Orekhov","year":"1985","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0051","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0021-9150(86)90002-X","article-title":"Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents","volume":"60","author":"Orekhov","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0052","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02059968","article-title":"Adult human aortic cells in primary culture: heterogeneity in shape","volume":"2","author":"Orekhov","year":"1986","journal-title":"Heart Vessels"},{"key":"10.1016\/j.phymed.2016.01.003_bib0053","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ddr.430090303","article-title":"Regression\" of atherosclerosis in cell culture: effects of stable prostacyclin analogues","volume":"9","author":"Orekhov","year":"1986","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0054","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0167-4889(87)90183-2","article-title":"Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta","volume":"928","author":"Orekhov","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2016.01.003_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9149(87)90971-4","article-title":"Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells","volume":"59","author":"Orekhov","year":"1987","journal-title":"Am. J. Cardiol."},{"issue":"Suppl 6","key":"10.1016\/j.phymed.2016.01.003_bib0056","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/00005344-198812006-00017","article-title":"Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells","volume":"12","author":"Orekhov","year":"1988","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0057","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0002-9149(88)90138-5","article-title":"Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta","volume":"61","author":"Orekhov","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0058","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0002-9149(90)91260-D","article-title":"In vitro models of antiatherosclerotic effects of cardiovascular drugs","volume":"66","author":"Orekhov","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0059","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.66.2.311","article-title":"Trigger-like stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells","volume":"66","author":"Orekhov","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0060","first-page":"139","article-title":"Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture","volume":"15","author":"Orekhov","year":"1990","journal-title":"Herz"},{"key":"10.1016\/j.phymed.2016.01.003_bib0061","first-page":"425","article-title":"Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists","volume":"5","author":"Orekhov","year":"1991","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phymed.2016.01.003_bib0062","first-page":"1","article-title":"Direct anti-atherosclerotic and anti-atherogenic effects of garlic","volume":"3A","author":"Orekhov","year":"1992","journal-title":"Eur. J. Clin. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0063","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11745-997-0136-7","article-title":"In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells","volume":"32","author":"Orekhov","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/j.phymed.2016.01.003_bib0064","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.2174\/1381612811319330011","article-title":"Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention","volume":"19","author":"Orekhov","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2016.01.003_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/18722083113079990008","article-title":"Anti-atherosclerotic therapy based on botanicals","volume":"8","author":"Orekhov","year":"2013","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"10.1016\/j.phymed.2016.01.003_bib0066","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/0003319714568792","article-title":"Effect of natural supplement containing curcuma longa, guggul, and chlorogenic acid in patients with metabolic syndrome","volume":"66","author":"Patti","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.phymed.2016.01.003_bib0067","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0003319714542999","article-title":"Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan","volume":"66","author":"Patti","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.phymed.2016.01.003_bib0069","first-page":"885","article-title":"Molecular regulation of cholesterol metabolism: HDL-based intervention through drugs and diet","volume":"51","author":"Rai","year":"2013","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0071","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/nure.12012","article-title":"Effect of garlic on serum lipids: an updated meta-analysis","volume":"71","author":"Ried","year":"2013","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.phymed.2016.01.003_bib0072","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0003319713493126","article-title":"Effects of chitosan on plasma lipids and lipoporoteins: a 4-month prospective pilot study","volume":"65","author":"Rizzo","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.phymed.2016.01.003_bib0073","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.92.7.1758","article-title":"Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries","volume":"92","author":"Salonen","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2016.01.003_bib0074","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2008.09.001","article-title":"Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome","volume":"204","author":"Sazonova","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0075","first-page":"129","article-title":"Ortologie und patologie der Langhans-zellen der aortenintima des menschen","volume":"33","author":"Sch\u00f6nfelder","year":"1969","journal-title":"Pathol. Microbiol. (Basel)"},{"key":"10.1016\/j.phymed.2016.01.003_bib0076","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/HCO.0b013e328357428a","article-title":"Medical therapy for peripheral arterial disease","volume":"27","author":"Simmons","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0077","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(94)90045-0","article-title":"Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages","volume":"105","author":"Sobenin","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0078","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0022-2275(20)32485-8","article-title":"Optimization of the assay for sialic acid determination in low density lipoprotein","volume":"39","author":"Sobenin","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0079","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1567-5688(03)91458-9","article-title":"Antiatherogenic properties of isoflavones from phytoestrogen-rich botanicals","volume":"4","author":"Sobenin","year":"2003","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.phymed.2016.01.003_bib0080","first-page":"491","article-title":"Antiatherogenic action of isoflavonoid-rich botanicals: an implementation for atherosclerosis prevention in postmenopausal women","volume":"7","author":"Sobenin","year":"2007","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00592-007-0011-x","article-title":"Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study","volume":"45","author":"Sobenin","year":"2008","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0082","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jacl.2008.08.059","article-title":"Atherosclerosis prevention in postmenopausal women with the isoflavonoid-rich dietary supplement Karinat","volume":"2","author":"Sobenin","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0083","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/hr.2009.36","article-title":"Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension","volume":"32","author":"Sobenin","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0084","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-511X-9-119","article-title":"The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease","volume":"9","author":"Sobenin","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phymed.2016.01.003_bib0085","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.2174\/1381612811319330014","article-title":"Blood atherogenicity as a target for anti-atherosclerotic therapy","volume":"19","author":"Sobenin","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2016.01.003_bib0086","first-page":"629","article-title":"The effects of garlic powder tablets in subclinical carotid atherosclerosis","volume":"20","author":"Sobenin","year":"2014","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0087","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/205697","article-title":"Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value","volume":"2014","author":"Sobenin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2016.01.003_bib0088","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ecl.2014.08.008","article-title":"New therapies for reducing low-density lipoprotein cholesterol","volume":"43","author":"Stein","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.phymed.2016.01.003_bib0089","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/0006-291X(82)91908-8","article-title":"Dibutyryl cyclic AMP decrease proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta","volume":"109","author":"Tertov","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2016.01.003_bib0044","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(85)92415-8","article-title":"LDL apheresis and regression of atherosclerosis","volume":"1","author":"Tertov","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2016.01.003_bib0091","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0021-9150(86)90019-5","article-title":"Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells","volume":"62","author":"Tertov","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0092","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0040-8166(87)90053-X","article-title":"Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta","volume":"19","author":"Tertov","year":"1987","journal-title":"Tissue Cell"},{"key":"10.1016\/j.phymed.2016.01.003_bib0093","first-page":"S286","article-title":"The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells","volume":"47","author":"Tertov","year":"1988","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.phymed.2016.01.003_bib0094","first-page":"665","article-title":"Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization","volume":"67","author":"Tertov","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phymed.2016.01.003_bib0095","first-page":"171","article-title":"Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells - the role of lipoprotein aggregation","volume":"30","author":"Tertov","year":"1992","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.phymed.2016.01.003_bib0096","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/clinchem\/41.7.1018","article-title":"Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay","volume":"41","author":"Tertov","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2016.01.003_bib0097","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/exmp.1995.1018","article-title":"Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions","volume":"62","author":"Tertov","year":"1995","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.phymed.2016.01.003_bib0098","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10715769609149054","article-title":"Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein","volume":"25","author":"Tertov","year":"1996","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.phymed.2016.01.003_bib0099","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(98)00023-9","article-title":"Low-density lipoprotein modification occurring in human plasma. Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification","volume":"138","author":"Tertov","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2016.01.003_bib0100","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2016.01.003_bib0101","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/circj.CJ-08-1169","article-title":"Endothelial dysfunction: the first step toward coronary atherosclerosis","volume":"73","author":"Vanhoutte","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.phymed.2016.01.003_bib0102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5482\/HAMO-13-09-0050","article-title":"Inflammatory mechanisms in atherosclerosis","volume":"34","author":"Wolf","year":"2014","journal-title":"Hamostaseologie"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711316000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711316000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:26:13Z","timestamp":1656941173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711316000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":89,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0944711316000192"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2016.01.003","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular models of atherosclerosis and their implication for testing natural substances with anti-atherosclerotic potential","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}